
    
      The study will be conducted at Kaiser Permanente Northern California and will commence with
      first use of licensed PENTACELÂ® vaccine within that organization.

      Vaccination databases will be reviewed to identify Diphtheria and tetanus toxoid with
      acellular pertussis (DTaP) vaccinations of accrued subjects. Medical encounter, emergency
      room, hospitalization, laboratory, state death reporting, and related databases will be
      reviewed to identify medical care events.
    
  